Jon Lee joins the podcast to discuss following the evidence and pharmacology research insights
This episode of Inside EMS is brought to you by Lexipol, the experts in policy, training, wellness support and grants assistance for first responders and government leaders. To learn more, visit lexipol.com.
In this episode, one of Chris Cebollero’s favorite authors, Jonathan Lee, joins Chris for a discussion of his most recent article, a research analysis examining the benefits of midazolam vs. morphine.
While morphine is the go-to drug when it comes to cardiac events, once you look at the research, there are some red flags, Lee notes.
Lee’s analysis focused on
Listen in to the discussion.
Resources mentioned in this episode
About our guest
Jonathan Lee is a critical care paramedic with Ornge in Toronto, Canada, with over 25 years of experience in 911, critical care, aeromedical and pediatric critical care transport. Jonathan’s teaching experience includes classroom, clinical and field education as well as curriculum development and design across a number of health professions.
He is currently delivering KinderMedic, a program he developed to improve the confidence and competence of prehospital providers caring for acutely ill children. In addition to his clinical practice, he is also adjunct faculty in the Paramedic Program at Georgian College. Jonathan is a freelance author and has been invited to speak across North America and Europe on topics such as pediatrics, analgesia and stress.
Jonathan has previously served on committees for professional organizations including the Ontario Paramedic Association and NAEMT. He is currently pursuing a Master of Science in Critical Care from Cardiff University. Jonathan can be contacted via Twitter and LinkedIn.
Rate and review Inside EMS
Enjoying the show? Please take a moment to rate and review us on Apple Podcasts. Contact the Inside EMS team at [email protected] to share ideas, suggestions and feedback, or if you’d like to join us as a guest.
Catch a new episode every Friday on Apple Podcasts, YouTube, PodBean, Amazon Music, Stitcher, Spotify, and RSS feed.